CTI BioPharma (CTIC) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Noncontrolling interest: 178K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Noncontrolling interest: 178K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q1 EPS of ($0.37), $0.04 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $13 million.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
